tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

Vanda Pharmaceuticals Inc

VNDA
Add to Watchlist
5.100USD
-0.080-1.54%
Close 07-31 16:00（ET）Quotes delayed by 15 min
306.69MMarket Cap
LossP/E TTM

Vanda Pharmaceuticals Inc

5.100
-0.080-1.54%
Overview
Financials
Discussions
Analysis
Company
Financial SummaryIncome StatementBalance SheetCash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial SummaryIncome StatementBalance SheetCash Flow Statement

VNDA Financials

See Vanda Pharmaceuticals Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Vanda Pharmaceuticals Inc Earnings Date

Latest Release
Aug 5, 2026
EPS / Forecast
--/-0.59
Revenue / Forecast
--/61.92M
See Upcoming Earnings >>
Period
FY2025 Earnings
Revenue(YoY)
216.10M
8.72%
EPS(YoY)
-3.74
-1051.06%
Analyst Rating
BUY
2026/08/02
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
-62.09%-0.82
-2735.85%-2.39
-318.28%-0.38
-494.30%-0.46
-602.05%-0.50
-102.50%-0.08
-3939.50%-0.09
-393.27%-0.08
-225.84%-0.07
-134.35%-0.04
--0.00
--0.03
--0.06
--0.12
---0.01
----
----
----
----
----
Revenue
3.35%51.72M
7.58%57.22M
18.06%56.26M
4.19%52.59M
5.43%50.04M
17.48%53.19M
22.76%47.65M
9.59%50.47M
-24.06%47.46M
-29.79%45.27M
-40.58%38.81M
-28.47%46.06M
3.83%62.50M
-5.20%64.48M
-6.82%65.32M
-5.17%64.39M
-3.95%60.19M
0.54%68.02M
16.23%70.09M
9.15%67.90M
Net Profit
-64.67%-48.57M
-2774.33%-141.19M
-324.23%-22.59M
-502.19%-27.21M
-611.38%-29.49M
-104.67%-4.91M
-3986.13%-5.32M
-397.24%-4.52M
-227.49%-4.15M
-134.98%-2.40M
-95.81%137.00K
-40.95%1.52M
150.58%3.25M
-3.07%6.86M
-57.92%3.27M
-73.33%2.57M
-174.34%-6.43M
-13.58%7.08M
30.67%7.77M
10.78%9.65M
Net Margin
-59.33%-93.91%
-2571.82%-246.76%
-259.33%-40.15%
-477.96%-51.73%
-574.72%-58.94%
-74.21%-9.24%
-3265.49%-11.17%
-371.22%-8.95%
-267.88%-8.74%
-149.82%-5.30%
--0.35%
--3.30%
--5.20%
--10.64%
---0.31%
----
----
----
----
----
Gross Margin
0.66%90.05%
-1.74%90.24%
0.73%91.63%
0.39%91.47%
1.09%89.46%
1.76%91.84%
-0.17%90.97%
-0.51%91.11%
-3.55%88.50%
0.57%90.25%
--91.13%
--91.58%
--91.75%
--89.74%
--89.90%
----
----
----
----
----
Debt to assets ratio
122.69%1.72%
102.37%1.53%
--0.86%
--0.85%
--0.77%
--0.76%
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Income Statement
Revenue
3.35%51.72M
7.58%57.22M
18.06%56.26M
4.19%52.59M
5.43%50.04M
17.48%53.19M
22.76%47.65M
9.59%50.47M
-24.06%47.46M
-29.79%45.27M
-40.58%38.81M
-28.47%46.06M
3.83%62.50M
-5.20%64.48M
-6.82%65.32M
-5.17%64.39M
-3.95%60.19M
0.54%68.02M
16.23%70.09M
9.15%67.90M
Operating profit
-22.41%-50.22M
-292.58%-40.35M
-184.40%-31.28M
-279.49%-38.50M
-344.27%-41.03M
-44.90%-10.28M
-83.49%-11.00M
-253.89%-10.15M
-560.83%-9.23M
-207.01%-7.09M
-253.40%-6.00M
-182.84%-2.87M
126.13%2.00M
-76.69%6.63M
-63.88%3.91M
-72.02%3.46M
-174.16%-7.67M
134.02%28.44M
23.76%10.82M
10.72%12.37M
Net Profit
-64.67%-48.57M
-2774.33%-141.19M
-324.23%-22.59M
-502.19%-27.21M
-611.38%-29.49M
-104.67%-4.91M
-3986.13%-5.32M
-397.24%-4.52M
-227.49%-4.15M
-134.98%-2.40M
-95.81%137.00K
-40.95%1.52M
150.58%3.25M
-3.07%6.86M
-57.92%3.27M
-73.33%2.57M
-174.34%-6.43M
-13.58%7.08M
30.67%7.77M
10.78%9.65M
Balance Sheet
Current assets
-28.13%293.17M
-20.88%347.26M
-15.01%367.50M
-10.08%394.92M
-7.17%407.91M
1.37%438.89M
-19.42%432.39M
-17.68%439.18M
-17.67%439.43M
-16.63%432.95M
5.81%536.57M
7.37%533.50M
8.42%533.71M
8.57%519.29M
9.81%507.11M
11.25%496.89M
16.87%492.27M
16.90%478.30M
18.55%461.81M
17.27%446.65M
Total current liabilities
30.46%135.58M
45.19%145.16M
32.30%117.87M
29.53%121.49M
11.34%103.92M
14.01%99.98M
5.01%89.09M
7.32%93.79M
-0.48%93.34M
-4.09%87.70M
-8.41%84.84M
-1.13%87.40M
3.36%93.79M
22.87%91.44M
28.65%92.62M
22.80%88.40M
46.87%90.74M
12.87%74.42M
17.34%72.00M
16.88%71.99M
Total assets
-31.40%433.52M
-25.49%488.95M
-6.82%601.14M
-4.09%624.75M
-3.18%631.94M
1.20%656.20M
0.55%645.12M
1.51%651.37M
1.26%652.68M
2.24%648.44M
3.19%641.61M
5.35%641.68M
6.79%644.53M
6.81%634.25M
7.25%621.79M
7.30%609.10M
11.11%603.56M
11.31%593.79M
12.38%579.77M
12.04%567.64M
Total liabilities
26.75%152.76M
37.48%161.76M
30.08%135.14M
27.16%138.42M
10.89%120.52M
13.65%117.66M
5.47%103.89M
6.95%108.86M
-0.10%108.69M
-3.29%103.53M
-7.19%98.50M
1.22%101.78M
7.25%108.79M
20.46%107.05M
22.77%106.13M
16.35%100.55M
34.24%101.44M
10.82%88.86M
14.75%86.45M
15.16%86.42M
Total equity
-45.10%280.76M
-39.25%327.19M
-13.90%466.00M
-10.36%486.33M
-5.99%511.42M
-1.17%538.55M
-0.35%541.22M
0.48%542.52M
1.54%544.00M
3.36%544.91M
5.32%543.10M
6.16%539.90M
6.69%535.74M
4.41%527.20M
4.53%515.66M
5.68%508.55M
7.38%502.12M
11.40%504.93M
11.97%493.32M
11.50%481.22M
Cash Flow Statement
Net operating income
-51.50%-50.22M
-1518.99%-29.42M
-116.90%-31.63M
-120.15%-15.25M
-537.93%-33.15M
51.31%-1.82M
-611.27%-14.58M
47.59%-6.93M
-76.20%7.57M
-139.63%-3.73M
-115.97%-2.05M
-332.54%-13.22M
686.04%31.80M
-64.61%9.42M
36.61%12.84M
-70.11%5.69M
-55.99%4.05M
37.85%26.61M
0.25%9.40M
-20.78%19.02M
Net investment
-53.91%20.23M
1023.62%44.87M
77.18%21.36M
-0.05%-15.27M
340.98%43.90M
109.12%3.99M
-65.87%12.06M
92.00%-15.26M
-109.73%-18.22M
-158.05%-43.78M
262.22%35.33M
-1208.21%-190.89M
1623.67%187.29M
390.13%75.43M
-31.28%-21.78M
57.31%-14.59M
15204.23%10.87M
-55.81%-26.00M
65.33%-16.59M
-1351.13%-34.18M
Net financing
41.39%-776.00K
-312.90%-640.00K
---517.00K
---425.00K
---1.32M
---155.00K
----
----
----
-100.00%0.00
-100.00%0.00
----
----
-41.88%605.00K
-98.92%4.00K
-56.75%125.00K
-100.00%0.00
-27.30%1.04M
201.63%371.00K
-91.97%289.00K

FAQs

What is the total revenue of Vanda Pharmaceuticals Inc?

According to Vanda Pharmaceuticals Inc's FY2025 earnings report, its total revenue reached 216.10M, with a year-on-year change of 198.77M.

What are the current assets of Vanda Pharmaceuticals Inc?

According to Vanda Pharmaceuticals Inc's FY2025 earnings report, its current assets were 347.26M, with a year-on-year change of -20.88.

What are the total assets of Vanda Pharmaceuticals Inc?

According to Vanda Pharmaceuticals Inc's FY2025 earnings report, its total assets of Vanda Pharmaceuticals Inc were 488.95M, with a year-on-year change of -25.49.

What are the total liabilities of Vanda Pharmaceuticals Inc?

According to Vanda Pharmaceuticals Inc's FY2025 earnings report, its total liabilities of Vanda Pharmaceuticals Inc were 161.76M, with a year-on-year change of 37.48.

What is the total equity of Vanda Pharmaceuticals Inc?

According to Vanda Pharmaceuticals Inc's FY2025 earnings report, its total equity of Vanda Pharmaceuticals Inc was 327.19M, with a year-on-year change of -39.25.

What is the net operating income of Vanda Pharmaceuticals Inc?

According to Vanda Pharmaceuticals Inc's FY2025 earnings report, its net operating income of Vanda Pharmaceuticals Inc was -151.17M, with a year-on-year change of -271.79.

What is the net investment of Vanda Pharmaceuticals Inc?

According to Vanda Pharmaceuticals Inc's FY2025 earnings report, its net investment of Vanda Pharmaceuticals Inc was 94.86M, with a year-on-year change of 644.23.

What is the net financing of Vanda Pharmaceuticals Inc?

According to Vanda Pharmaceuticals Inc's FY2025 earnings report, its net financing of Vanda Pharmaceuticals Inc was -2.91M, with a year-on-year change of -1774.84.

What is the Earnings Per Share (EPS) of Vanda Pharmaceuticals Inc?

According to Vanda Pharmaceuticals Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -3.74, with a year-on-year change of -1051.06.

What is the net income of Vanda Pharmaceuticals Inc?

According to Vanda Pharmaceuticals Inc's FY2025 earnings report, its net income was -220.47M, with a year-on-year change of -1066.53.

What is the net margin of Vanda Pharmaceuticals Inc?

According to Vanda Pharmaceuticals Inc's FY2025 earnings report, its net profit margin was -102.02, with a year-on-year change of -972.97.

What is the gross margin of Vanda Pharmaceuticals Inc?

According to Vanda Pharmaceuticals Inc's FY2025 earnings report, its gross margin was 90.72, with a year-on-year change of 0.08.

What is the debt-to-asset ratio of Vanda Pharmaceuticals Inc?

According to Vanda Pharmaceuticals Inc's FY2025 earnings report, its debt-to-asset ratio was 1.53, with a year-on-year change of 102.37.

What is the Return on Equity (ROE) of Vanda Pharmaceuticals Inc?

According to Vanda Pharmaceuticals Inc's FY2025 earnings report, its Return on Equity (ROE) was -50.93, with a year-on-year change of -1359.90.

What is the Return on Assets (ROA) of Vanda Pharmaceuticals Inc?

According to Vanda Pharmaceuticals Inc's FY2025 earnings report, its Return on Assets (ROA) was -38.51, with a year-on-year change of -1229.00.

What is the operating profit of Vanda Pharmaceuticals Inc?

According to Vanda Pharmaceuticals Inc's FY2025 earnings report, its operating profit was -151.17M, with a year-on-year change of -271.79.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy